Our mission is to revolutionize the treatment landscape for cancer and neurodegenerative diseases by pioneering “oncodegenic” innovations. By deeply understanding the biology at the intersection of cancer and degeneration and leveraging insights from prion biology and advanced cancer treatment methodologies, we aim to develop groundbreaking therapeutic strategies that transform patient care and outcomes across both disease states
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1201 W Peachtree St Nw, Atlanta,georgia 30309,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.dimerpharma.com
- Keywords
- Alzheimer's disease, Diffuse Intrinsic Pontine Glioma, Pediatric High Risk Neural Tumors, Chaperone modulators.
- HQ
- Atlanta, Georgia
Dimer Pharmaceuticals Questions
Dimer Pharmaceuticals's website is http://www.dimerpharma.com
Dimer Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/dimerpharma
Dimer Pharmaceuticals has
1 employees.
View email and phone details for 1
employees at Dimer Pharmaceuticals.
Dimer Pharmaceuticals's industry is
Biotechnology Research
Dimer Pharmaceuticals's top competitors are
Coalition Against Childhood Cancer (Cac2),
Quralis,
Micron Biomedical,
Raybiotech,
Caprico Biotechnologies, Inc.,
Lena Biosciences,
Omega Bio-Tek,
Georgia Life Sciences,
Akesogen, Inc.,
Avion Pharmaceuticals.
Dimer Pharmaceuticals's categories are Biotechnology Research
Dimer Pharmaceuticals's founding year is 2024
